Metabolic syndrome: An ill wind that blows some good?

od Taylor, Simeon I.
izdano v Diabetes Metab Res Rev (2015)

GLP-1 receptor agonists: differentiation within the class

od Taylor, Simeon I.
izdano v Lancet Diabetes Endocrinol (2017)

Letter to the Editor: “Hypertension and Type 2 Diabetes Are Associated With Decreased Inhibition of Dipeptidyl Peptidase-4 by Sitagliptin”

od Taylor, Simeon I
izdano v J Endocr Soc (2020)

The High Cost of Diabetes Drugs: Disparate Impact on the Most Vulnerable Patients

od Taylor, Simeon I.
izdano v Diabetes Care (2020)

Insulin: still a miracle after all these years

od Barbetti, Fabrizio, Taylor, Simeon I.
izdano v J Clin Invest (2019)

Cardiovascular outcome trials of diabetes drugs: lessons learned

od Taylor, Simeon I., Leslie, Bruce R.
izdano v J Clin Invest (2018)

Adverse effects of SGLT2 inhibitors on bone

od Blau, Jenny E., Taylor, Simeon I.
izdano v Nat Rev Nephrol (2018)

YIPF5 mutations cause neonatal diabetes and microcephaly: progress for precision medicine and mechanistic understanding

od Pollin, Toni I., Taylor, Simeon I.
izdano v J Clin Invest (2020)

Smarter Modeling to Enable a Smarter Insulin

od Taylor, Simeon I., DiMarchi, Richard D.
izdano v Diabetes (2020)

SGLT2 Inhibitors May Predispose to Ketoacidosis

od Taylor, Simeon I., Blau, Jenny E., Rother, Kristina I.
izdano v J Clin Endocrinol Metab (2015)

SGLT2-inhibitors Trigger Downstream Mechanisms That May Exert Adverse Effects Upon Bone

od Taylor, Simeon I., Blau, Jenny E., Rother, Kristina I.
izdano v Lancet Diabetes Endocrinol (2014)

Sodium–Glucose Cotransporter 2 Inhibitors: A Case Study in Translational Research

od Beitelshees, Amber L., Leslie, Bruce R., Taylor, Simeon I.
izdano v Diabetes (2019)

Pharmacological treatment of hyperglycemia in type 2 diabetes

od Taylor, Simeon I., Yazdi, Zhinous Shahidzadeh, Beitelshees, Amber L.
izdano v J Clin Invest (2021)

Ketoacidosis associated with SGLT2 inhibitor treatment: Analysis of FAERS data

od Blau, Jenny E., Tella, Sri Harsha, Taylor, Simeon I., Rother, Kristina I.
izdano v Diabetes Metab Res Rev (2017)

SGLT2 Inhibitors as Adjunctive Therapy for Type 1 Diabetes: Balancing Benefits versus Risks

od Taylor, Simeon I., Blau, Jenny E., Rother, Kristina I., Beitelshees, Amber L.
izdano v Lancet Diabetes Endocrinol (2019)

Identification of a Family of Sorting Nexin Molecules and Characterization of Their Association with Receptors

od Haft, Carol Renfrew, de la Luz Sierra, Maria, Barr, Valarie A., Haft, Daniel H., Taylor, Simeon I.
Izdano 1998

Human Orthologs of Yeast Vacuolar Protein Sorting Proteins Vps26, 29, and 35: Assembly into Multimeric Complexes

od Haft, Carol Renfrew, Sierra, Maria de la Luz, Bafford, Richard, Lesniak, Maxine A., Barr, Valarie A., Taylor, Simeon I.
Izdano 2000

Mutational and Haplotype Analyses of Families with Familial Partial Lipodystrophy (Dunnigan Variety) Reveal Recurrent Missense Mutations in the Globular C-Terminal Domain of Lamin...

od Speckman, Rebecca A., Garg, Abhimanyu, Du, Fenghe, Bennett, Lynda, Veile, Rose, Arioglu, Elif, Taylor, Simeon I., Lovett, Michael, Bowcock, Anne M.
Izdano 2000

The complicated clinical course in a case of atypical lipodystrophy after development of neutralizing antibody to metreleptin: treatment with setmelanotide

od Akinci, Baris, Meral, Rasimcan, Rus, Diana, Hench, Rita, Neidert, Adam H, DiPaola, Frank, Westerhoff, Maria, Taylor, Simeon I, Oral, Elif A
izdano v Endocrinol Diabetes Metab Case Rep (2020)

Erratum. Insulin Access and Affordability Working Group: Conclusions and Recommendations. Diabetes Care 2018;41;1299–1311

od Cefalu, William T., Dawes, Daniel E., Gavlak, Gina, Goldman, Dana, Herman, William H., Van Nuys, Karen, Powers, Alvin C., Taylor, Simeon I., Yatvin, Alan L.
izdano v Diabetes Care (2018)